Creative Planning’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,858
Closed -$230K 3096
2023
Q2
$230K Buy
+5,858
New +$207K ﹤0.01% 2108
2022
Q3
Sell
-28,790
Closed -$277K 2480
2022
Q2
$277K Buy
28,790
+160
+0.6% +$2.01K ﹤0.01% 1668
2022
Q1
$482K Hold
28,630
﹤0.01% 1336
2021
Q4
$479K Hold
28,630
﹤0.01% 1328
2021
Q3
$465K Sell
28,630
-25,645
-47% -$279K ﹤0.01% 1347
2021
Q2
$342K Sell
54,275
-646
-1% -$4.17K ﹤0.01% 1496
2021
Q1
$339K Hold
54,921
﹤0.01% 1719
2020
Q4
$380K Hold
54,921
﹤0.01% 1470
2020
Q3
$310K Hold
54,921
﹤0.01% 1405
2020
Q2
$280K Hold
54,921
﹤0.01% 1354
2020
Q1
$189K Hold
54,921
﹤0.01% 1406
2019
Q4
$471K Hold
54,921
﹤0.01% 1143
2019
Q3
$62K Hold
54,921
﹤0.01% 1770
2019
Q2
$71K Hold
54,921
﹤0.01% 1781
2019
Q1
$77K Buy
54,921
+646
+1% +$903 ﹤0.01% 1741
2018
Q4
$65K Hold
54,275
﹤0.01% 1683
2018
Q3
$128K Hold
54,275
﹤0.01% 1753
2018
Q2
$148K Hold
54,275
﹤0.01% 1697
2018
Q1
$149K Buy
54,275
+1,200
+2% +$3.48K ﹤0.01% 1679
2017
Q4
$166K Hold
53,075
﹤0.01% 1656
2017
Q3
$150K Buy
53,075
+6,134
+13% +$16.6K ﹤0.01% 1662
2017
Q2
$120K Buy
46,941
+45,996
+4,867% +$125K ﹤0.01% 1859
2017
Q1
$3K Buy
945
+645
+215% +$2.73K ﹤0.01% 4200
2016
Q4
$1K Sell
300
-5,000
-94% -$148K ﹤0.01% 4526
2016
Q3
$244K Sell
5,300
-227
-4% -$12.8K ﹤0.01% 1295
2016
Q2
$282K Buy
5,527
+2,100
+61% +$104K ﹤0.01% 1085
2016
Q1
$145K Buy
+3,427
New +$175K ﹤0.01% 1399

Creative Planning's ISEE Position: Q3 2023 in Review

Creative Planning sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 5,858 shares — an estimated $230K sold.

Creative Planning first reported a position in ISEE in Q1 2016 and held it in 27 quarters. The position peaked at $482K in Q1 2022. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Creative Planning reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Creative Planning sold 5,858 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $230K.
  • Creative Planning first reported a position in IVERIC bio, Inc. Common Stock in Q1 2016 and held it in 27 quarters.
  • Creative Planning's IVERIC bio, Inc. Common Stock position peaked at $482K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Creative Planning's 13F filing for Q3 2023, filed 16 Nov 2023.